Eagle Ridge Investment Management bought a new stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 5,818 shares of the pharmacy operator’s stock, valued at approximately $449,000.
A number of other hedge funds also recently modified their holdings of WBA. Vanguard Group Inc. raised its holdings in shares of Walgreens Boots Alliance by 2.8% during the second quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock valued at $5,480,577,000 after buying an additional 1,926,108 shares during the last quarter. Wellington Management Group LLP raised its holdings in shares of Walgreens Boots Alliance by 5.9% during the first quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after buying an additional 1,824,300 shares during the last quarter. Franklin Resources Inc. raised its holdings in Walgreens Boots Alliance by 24.7% during the second quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock worth $1,448,939,000 after purchasing an additional 3,662,302 shares in the last quarter. Nordea Investment Management AB raised its holdings in Walgreens Boots Alliance by 10.2% during the second quarter. Nordea Investment Management AB now owns 10,085,836 shares of the pharmacy operator’s stock worth $789,822,000 after purchasing an additional 931,508 shares in the last quarter. Finally, CI Global Investments Inc. raised its holdings in Walgreens Boots Alliance by 4.8% during the second quarter. CI Global Investments Inc. now owns 5,931,592 shares of the pharmacy operator’s stock worth $464,503,000 after purchasing an additional 270,182 shares in the last quarter. Institutional investors own 61.41% of the company’s stock.
In other news, Director John Anthony Lederer acquired 20,000 shares of the stock in a transaction on Thursday, October 26th. The shares were purchased at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares in the company, valued at $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is currently owned by corporate insiders.
Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $71.72 on Thursday. The stock has a market capitalization of $71,030.00, a price-to-earnings ratio of 14.09, a price-to-earnings-growth ratio of 1.28 and a beta of 1.22. Walgreens Boots Alliance Inc has a twelve month low of $63.82 and a twelve month high of $88.00. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.21 by $0.10. The company had revenue of $30.15 billion for the quarter, compared to analysts’ expectations of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.07 earnings per share. equities research analysts forecast that Walgreens Boots Alliance Inc will post 5.54 EPS for the current fiscal year.
Walgreens Boots Alliance declared that its board has authorized a stock repurchase program on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to repurchase shares of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board believes its stock is undervalued.
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were issued a $0.40 dividend. The ex-dividend date of this dividend was Friday, November 10th. This represents a $1.60 annualized dividend and a dividend yield of 2.23%. Walgreens Boots Alliance’s dividend payout ratio is currently 42.33%.
Several brokerages recently commented on WBA. Needham & Company LLC dropped their target price on Walgreens Boots Alliance to $86.00 and set a “buy” rating on the stock in a report on Wednesday, November 22nd. Jefferies Group set a $93.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Sunday, October 29th. Vetr raised Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday. BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, November 10th. Finally, Zacks Investment Research raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Thursday, October 5th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $86.47.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.